E-ISSN 2534-9821
 

Case Report 


Efficacy and safety of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH) after 15 years steroids treatment: a case report description

Endri Mauro, Filippo Gherlinzoni.

Abstract
Background Paroxysmal Nocturnal Hemoglobinuria (PNH) pathogenesis is due to acquired lack of glycosylphosphatidylinositol-anchored protein complement regulatory proteins (CD55 and CD59) and intra-extravascular hemolysis. Eculizumab is a monoclonal antibody binding complement protein 5 (C5 receptor CD59), blocking complement upstream and reducing hemolysis. Case Summary In 1999 we diagnosed PNH in a male 54 year-old. Therapy with prednisone and blood transfusions started. After 13 years (2012) of continuative steroid, we started eculizumab every 14 days. Clinical and laboratory improvement has been reported, the prednisone therapy has been tapered; no further hemolytic crises reappeared. However, mild anemia, high reticulocytes count, high LDH serum levels are still reported. Actually, despite to suboptimal response, the patient shows a good quality of life. Conclusion Here we report a case of PNH with a fully documented medical history of long-term steroid therapy confirming efficacy and safety of eculizumab. However “C3 tick over” effect may induce suboptimal clinical results with residual hemolytic activity also on heavy steroid treated patients.

Key words: paroxysmal nocturnal hemoglobinuria, eculizumab, steroids, hemolysis


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Endri Mauro
Articles by Filippo Gherlinzoni
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Mauro E, Gherlinzoni F, . Efficacy and safety of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH) after 15 years steroids treatment: a case report description. Int J Med Rev Case Rep. 2019; 3(11): 773-776. doi:10.5455/IJMRCR.Eculizumab-Paroxysmal-Nocturnal-Hemoglobinuria


Web Style

Mauro E, Gherlinzoni F, . Efficacy and safety of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH) after 15 years steroids treatment: a case report description. http://www.mdpub.net/?mno=63629 [Access: May 31, 2020]. doi:10.5455/IJMRCR.Eculizumab-Paroxysmal-Nocturnal-Hemoglobinuria


AMA (American Medical Association) Style

Mauro E, Gherlinzoni F, . Efficacy and safety of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH) after 15 years steroids treatment: a case report description. Int J Med Rev Case Rep. 2019; 3(11): 773-776. doi:10.5455/IJMRCR.Eculizumab-Paroxysmal-Nocturnal-Hemoglobinuria



Vancouver/ICMJE Style

Mauro E, Gherlinzoni F, . Efficacy and safety of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH) after 15 years steroids treatment: a case report description. Int J Med Rev Case Rep. (2019), [cited May 31, 2020]; 3(11): 773-776. doi:10.5455/IJMRCR.Eculizumab-Paroxysmal-Nocturnal-Hemoglobinuria



Harvard Style

Mauro, E. ., Gherlinzoni, F. & (2019) Efficacy and safety of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH) after 15 years steroids treatment: a case report description. Int J Med Rev Case Rep, 3 (11), 773-776. doi:10.5455/IJMRCR.Eculizumab-Paroxysmal-Nocturnal-Hemoglobinuria



Turabian Style

Mauro, Endri , Filippo Gherlinzoni, and . 2019. Efficacy and safety of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH) after 15 years steroids treatment: a case report description. International Journal of Medical Reviews and Case Reports, 3 (11), 773-776. doi:10.5455/IJMRCR.Eculizumab-Paroxysmal-Nocturnal-Hemoglobinuria



Chicago Style

Mauro, Endri , Filippo Gherlinzoni, and . "Efficacy and safety of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH) after 15 years steroids treatment: a case report description." International Journal of Medical Reviews and Case Reports 3 (2019), 773-776. doi:10.5455/IJMRCR.Eculizumab-Paroxysmal-Nocturnal-Hemoglobinuria



MLA (The Modern Language Association) Style

Mauro, Endri , Filippo Gherlinzoni, and . "Efficacy and safety of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH) after 15 years steroids treatment: a case report description." International Journal of Medical Reviews and Case Reports 3.11 (2019), 773-776. Print. doi:10.5455/IJMRCR.Eculizumab-Paroxysmal-Nocturnal-Hemoglobinuria



APA (American Psychological Association) Style

Mauro, E. ., Gherlinzoni, F. & (2019) Efficacy and safety of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH) after 15 years steroids treatment: a case report description. International Journal of Medical Reviews and Case Reports, 3 (11), 773-776. doi:10.5455/IJMRCR.Eculizumab-Paroxysmal-Nocturnal-Hemoglobinuria